DIH Holding US, Inc.

DHAI Healthcare Medical Devices

DIH Holding US, Inc.’s revenue for fiscal 2025 (year ended March 2025) was $62.9 million, down 2.50% from fiscal 2024. In the quarter to March 2025, revenue fell 30.7%, EPS grew 30.0% and free cash flow fell 167.9%, each against the same quarter a year earlier.

0.00 0.00 NaN
Market cap
$1.6M
P/E
0.0×
Fwd P/E
—
Dividend yield
—
F-score
4/9
Altman Z
−1.78
Beneish M
−3.91
Dividend safety
n/a
Mar '25 Dec '24 Sep '24 Jun '24 Older periods
ROE
24.90% 42.51% 28.72% 39.51%

+8 more TTM periods

ROA
(27.77%) (23.71%) (13.27%) (7.20%)
ROIC
0.00% 0.00% 0.00% 0.00%
Return on Tangible Assets
41.04% 47.17% 34.76% 48.26%
Average Days of Receivables
39.00 53.94 68.42 67.60
Free Cash Flow per Share
(81.82) 2.67 2.00 3.40
Free Cash Flow
(4.68) 3.70 2.77 4.70
Other line items

Show all line items

Columns are period end dates · fundamentals updated 28 Sep 2026